Summer Sale
50% off Premium Yearly
NASDAQ:MYOK
MyoKardia (MYOK)
Financials 
Technical Analysis https://www.businesswire.com/news/home/20201005005381/en/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash Today, Bristol Myers announced it's buying MyoKardia (MYOK-Q) ifor US$13.1 billion cash. MyoKardia makes drugs to fight heart disease and heart conditions, including mavacamten, a drug for which they will file an application in Q1-2021. The stock has gotten really cheap. He loves this deal.
- «
- ‹
- 1
- ›
- »
MyoKardia (MYOK) Frequently Asked Questions
What is MyoKardia stock symbol?
MyoKardia is a American stock, trading under the symbol MYOK (previously MYOK-Q on Stockchase) on the NASDAQ (MYOK). It is usually referred to as NASDAQ:MYOK or MYOK
Is MyoKardia a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on MYOK (previously MYOK-Q on Stockchase) on Stockchase. Read the latest expert commentary for MyoKardia.
Is MyoKardia a good investment or a top pick?
MyoKardia was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for MyoKardia.
Why is MyoKardia stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for MyoKardia.
Is MyoKardia worth watching?
MyoKardia is covered by Stockchase experts and is worth watching.
What is MyoKardia stock price?
On 2020-11-16, MyoKardia (MYOK) stock closed at a price of $224.92.
